Related Experiment Videos
Indications for keratoepithelioplasty.
P W Turgeon1, R C Nauheim, M I Roat
1Eye and Ear Institute, University of Pittsburgh, PA 15213.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|February 1, 1990
Summary
Keratoepithelioplasty using corneal limbal epithelial cells shows promise for treating ocular surface failure. This innovative procedure successfully healed persistent epithelial defects and improved superficial keratopathies in several patients.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Tissue Engineering
Background:
- Chronic ocular surface failure poses a significant challenge in ophthalmology.
- Conventional medical management often proves insufficient for persistent epithelial defects and severe keratopathies.
- Limbal stem cell deficiency can lead to ocular surface instability and visual impairment.
Observation:
- Thirteen patients with ocular surface failure underwent keratoepithelioplasty using allografts of corneal limbal epithelial cells.
- The procedure involved transplanting epithelial cells derived from donor corneas.
- Follow-up periods ranged from 4 to 19 months for some patients.
Findings:
- Successful long-term healing of persistent epithelial defects was observed in five out of eight treated eyes.
- Three out of five patients with superficial keratopathies achieved a stable and clear optical surface post-procedure.
- The study demonstrated the potential of epithelial transplantation to restore ocular surface integrity.
Implications:
- Epithelial transplantation represents a viable therapeutic option for chronic ocular surface failure.
- This technique may offer a solution for patients unresponsive to traditional treatments.
- Further research into limbal epithelial cell transplantation could advance the management of complex corneal diseases.